Our customer was conducting a Phase III Oncology clinical trial. The initial request was for local sourcing over 80 countries.
Our Customer was conducting a Global Phase II trial; the product required was a high value disease-modifying drug that was tightly watched by manufacturer
Bio Similar Case Study. Through our approved supplier source, we were able to secure a high value drug, within the time scale allotted for the trial.